• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Int J Med Sci . Identification of parameters in routine blood and coagulation tests related to the severity of COVID-19

tetano

Editor, Senior Moderator
Int J Med Sci


. 2021 Jan 14;18(5):1207-1215.
doi: 10.7150/ijms.47494. eCollection 2021.
Identification of parameters in routine blood and coagulation tests related to the severity of COVID-19


Rongrong Ding[SUP] 1 [/SUP], Zongguo Yang[SUP] 2 [/SUP], Dan Huang[SUP] 1 [/SUP], Yanbing Wang[SUP] 1 [/SUP], Xiufen Li[SUP] 1 [/SUP], Xinlan Zhou[SUP] 1 [/SUP], Li Yan[SUP] 1 [/SUP], Wei Lu[SUP] 1 [/SUP], Zhanqing Zhang[SUP] 1 [/SUP]



Affiliations

Abstract

Objective: This study aimed to identify the predictive value of simple markers in routine blood and coagulation tests for the severity of coronavirus disease 2019 (COVID-19). Methods: A total of 311 consecutive COVID-19 patients, including 281 patients with mild/moderate COVID-19 and 30 patients with severe/life-threatening COVID-19, were retrospectively enrolled. Logistic modeling and ROC curve analyses were used to assess the indexes for identifying disease severity. Results: Lymphocyte and eosinophil counts of COVID-19 patients in the severe/life-threatening group were significantly lower than those of patients in the mild/moderate group (P < 0.001). Coagulation parameters, high-sensitivity C-reactive protein (hsCRP) levels and procalcitonin levels were higher in the severe/life-threatening group compared with the mild/moderate group (all P < 0.05). Univariate and multivariate logistic models revealed that hsCRP and fibrinogen degradation products (FDPs) were predictors of severe COVID-19 (OR = 1.072, P = 0.036; and OR = 1.831, P = 0.036, respectively). The AUROCs of hsCRP and FDP for predicting severe/life-threatening COVID-19 were 0.850 and 0.766, respectively. The optimal cutoffs of hsCRP and FDP for the severe/life-threatening type of COVID-19 were 22.41 mg/L and 0.95 ?g/ml, respectively. Conclusion: Serum CRP and FDP levels are positively related to the severity of COVID-19. This finding indicates that CRP and FDP levels may potentially be used as early predictors for severe illness and help physicians triage numerous patients in a short time.

Keywords: COVID-19; Coronavirus disease 2019; FDP; fibrinogen degradation products; highly sensitive C-reactive protein.
 
Back
Top Bottom